[go: up one dir, main page]

MXPA03006742A - Uso de buprenorfina para la terapia de la incontinencia urinaria. - Google Patents

Uso de buprenorfina para la terapia de la incontinencia urinaria.

Info

Publication number
MXPA03006742A
MXPA03006742A MXPA03006742A MXPA03006742A MXPA03006742A MX PA03006742 A MXPA03006742 A MX PA03006742A MX PA03006742 A MXPA03006742 A MX PA03006742A MX PA03006742 A MXPA03006742 A MX PA03006742A MX PA03006742 A MXPA03006742 A MX PA03006742A
Authority
MX
Mexico
Prior art keywords
buprenorphine
urinary incontinence
utilization
incontinence therapy
therapy
Prior art date
Application number
MXPA03006742A
Other languages
English (en)
Inventor
Johannes Bartholomeus
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2001107828 external-priority patent/DE10107828A1/de
Priority claimed from DE20115429U external-priority patent/DE20115429U1/de
Priority claimed from DE2001162704 external-priority patent/DE10162704A1/de
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of MXPA03006742A publication Critical patent/MXPA03006742A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/305—Mercury compounds
    • A61K31/31—Mercury compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA03006742A 2001-02-16 2002-02-18 Uso de buprenorfina para la terapia de la incontinencia urinaria. MXPA03006742A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2001107828 DE10107828A1 (de) 2001-02-16 2001-02-16 Verwendung von Buprenorphin zur Therapie der Harninkontinenz
DE20115429U DE20115429U1 (de) 2001-09-18 2001-09-18 Opioide in der Harninkontinenz
DE2001162704 DE10162704A1 (de) 2001-12-19 2001-12-19 Verwendung von Buprenorphin zur Therapie der Harninkontinenz
PCT/EP2002/001699 WO2002066031A1 (de) 2001-02-16 2002-02-18 Verwendung von buprenorphin zur therapie der harninkontinenz

Publications (1)

Publication Number Publication Date
MXPA03006742A true MXPA03006742A (es) 2003-10-24

Family

ID=27214302

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03006742A MXPA03006742A (es) 2001-02-16 2002-02-18 Uso de buprenorfina para la terapia de la incontinencia urinaria.

Country Status (14)

Country Link
US (1) US20040102468A1 (es)
EP (1) EP1368023B1 (es)
JP (1) JP4908726B2 (es)
AT (1) ATE314066T1 (es)
AU (1) AU2002242705B2 (es)
CA (1) CA2438339C (es)
DE (1) DE50205438D1 (es)
DK (1) DK1368023T3 (es)
ES (1) ES2255607T3 (es)
HU (1) HU229354B1 (es)
MX (1) MXPA03006742A (es)
NZ (1) NZ528064A (es)
PL (1) PL204638B1 (es)
WO (1) WO2002066031A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1323421A1 (en) * 2001-12-20 2003-07-02 Grünenthal GmbH Use of buprenorphine for the manufacture of a transdermal delivery device for the treatment of urinary incontinence, especially urge incontinence
WO2005034754A1 (en) 2003-10-15 2005-04-21 The University Of British Columbia Methods and apparatus for urodynamic analysis
US8260389B2 (en) * 2003-10-15 2012-09-04 Hegln (Dalian) Pharmaceuticals, Inc. Bladder function monitoring methods, apparatuses, media and signals
US11547676B2 (en) * 2012-12-28 2023-01-10 Teikoku Seiyaku Co., Ltd. Extended buprenorphine transdermal delivery compositions and methods for using the same
EP3067357A1 (en) 2015-03-11 2016-09-14 Siegfried AG Method of manufacturing stereoisomers of buprenorphine and analogues thereof
CN107320770A (zh) * 2017-07-12 2017-11-07 江苏西宏生物医药有限公司 一种注射植入剂
EP4613751A1 (en) 2024-03-07 2025-09-10 Siegfried AG Method of making chemical compounds useful for the synthesis of buprenorphine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486362A (en) * 1991-05-07 1996-01-23 Dynagen, Inc. Controlled, sustained release delivery system for treating drug dependency
DE4446600A1 (de) * 1994-12-24 1996-06-27 Lohmann Therapie Syst Lts Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen
AU5090796A (en) * 1995-03-03 1996-09-23 Algos Pharmaceutical Corporation Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
JPH1036265A (ja) * 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5900420A (en) * 1997-06-19 1999-05-04 Cole; William L. Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
IT1302682B1 (it) * 1998-10-16 2000-09-29 Formenti Farmaceutici Spa Composizioni farmaceutiche orali contenenti buprenorfina

Also Published As

Publication number Publication date
US20040102468A1 (en) 2004-05-27
DE50205438D1 (de) 2006-02-02
HUP0302984A3 (en) 2006-02-28
PL367401A1 (en) 2005-02-21
ES2255607T3 (es) 2006-07-01
AU2002242705B2 (en) 2006-08-24
WO2002066031A1 (de) 2002-08-29
HU229354B1 (en) 2013-11-28
EP1368023A1 (de) 2003-12-10
NZ528064A (en) 2006-03-31
JP2004525900A (ja) 2004-08-26
HUP0302984A2 (hu) 2003-12-29
CA2438339A1 (en) 2002-08-29
DK1368023T3 (da) 2006-02-13
JP4908726B2 (ja) 2012-04-04
CA2438339C (en) 2010-12-14
EP1368023B1 (de) 2005-12-28
ATE314066T1 (de) 2006-01-15
PL204638B1 (pl) 2010-01-29

Similar Documents

Publication Publication Date Title
WO2001030381A3 (de) Verwendung von csf-1-inhibitoren
AU2001282717A1 (en) Cancer treatment by combination therapy
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
AU2001294604A1 (en) Improved radiation therapy treatment method
MY137757A (en) Therapeutic treatment
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
AU2003206760A1 (en) Anticholinergic agents, method for producing the same and use thereof as medicaments
MXPA03000188A (es) Metodo de tratamiento de enfermedades relacionadas con neutroficos con anestesicos locales.
WO2000066528A3 (en) Quinones for treatment of diseases
HK1047707A1 (zh) (+)-曲马朵、o-去甲曲马朵或(+)-o-去甲曲马朵、o-去甲-n-单-去甲-曲马朵或(+)-o-去甲-n-单-去甲-曲马朵治疗尿失禁的用途
WO2003039539A3 (de) Verwendung von endothelin-rezeptor-antagonisten zur behandlung von tumorerkrankungen
AU2001222215A1 (en) Lumbago treating girdle
HUP0401760A3 (en) Stent, process for production thereof and its use for treating for restenosen and/or trombozen
PL367401A1 (en) Utilization of buprenorphine in urinary incontinence therapy
AU3321002A (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
SI1596879T1 (sl) Uporaba spojine kahalalida za pripravo zdravila za zdravljenje luskavice
WO2000069841A3 (en) Benzofuranylaminoalcohols
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
WO2002043712A3 (de) Verwendung von 6-dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur therapie der harninkontinenz
ZA200405173B (en) 2'-halo-3',5'-dialkoxyphen-1'yl-imino-2-imidazoline derivatives and the use thereof for the treatment of urinary incontinence.
AU2001276323A1 (en) Use of n-oleoylethanolamine for treating psoriasis
WO2004037278A3 (de) Dyslokalisationsmoleküle und deren verwendung
AU2002329244A1 (en) Cell compositions for use in the treatment of osteo-arthrosis, and method for producing the same
AU2002320683A1 (en) Laminates for treating cornea and process for producing the same
UA34368A (uk) Спосіб лікування рака молочної залози

Legal Events

Date Code Title Description
FG Grant or registration